Small cationic DDA:TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responses.
Most subunit vaccines require adjuvants in order to induce protective immune responses to the targeted pathogen. However, many of the potent immunogenic adjuvants display unacceptable local or systemic reactogenicity. Liposomes are spherical vesicles consisting of single (unilamellar) or multiple (m...
Main Authors: | Milicic, A, Kaur, R, Reyes-Sandoval, A, Tang, C, Honeycutt, J, Perrie, Y, Hill, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2012
|
Similar Items
-
Addition of immunostimulatory components to DDA-TDB adjuvant delivery system
by: Kaur, R, et al.
Published: (2010) -
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells
by: Julie Zimmermann, et al.
Published: (2023-12-01) -
Author Correction: Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells
by: Julie Zimmermann, et al.
Published: (2024-01-01) -
Liposomes as vaccine adjuvants
by: Milicic, A, et al.
Published: (2010) -
Enhancement of the effect of BCG vaccine against tuberculosis using DDA/TDB liposomes containing a fusion protein of HspX, PPE44, and EsxV
by: Davood Mansury, et al.
Published: (2019-12-01)